These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 30467064

  • 1. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE, Derbise A, Guillas C, Gerke C, Cauchemez S, Carniel E, Pizarro-Cerdá J.
    Vaccine; 2019 Jan 03; 37(1):123-129. PubMed ID: 30467064
    [Abstract] [Full Text] [Related]

  • 2. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.
    PLoS Negl Trop Dis; 2015 Jan 03; 9(10):e0004162. PubMed ID: 26473734
    [Abstract] [Full Text] [Related]

  • 3. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.
    PLoS Negl Trop Dis; 2012 Jan 03; 6(2):e1528. PubMed ID: 22348169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.
    Singh AK, Curtiss R, Sun W.
    Infect Immun; 2019 Oct 03; 87(10):. PubMed ID: 31331960
    [Abstract] [Full Text] [Related]

  • 6. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST.
    Vaccine; 2010 Dec 16; 29(2):357-62. PubMed ID: 20840834
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Delivery of Yersinia pestis antigens via Escherichia coli outer membrane vesicles offered improved protection against plague.
    Tong Z, Zhang X, Guo X, Wu G, Cao S, Zhang Y, Meng X, Wang T, Wang Y, Song Y, Yang R, Du Z.
    mSphere; 2024 Sep 25; 9(9):e0033024. PubMed ID: 39158304
    [Abstract] [Full Text] [Related]

  • 10. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB, Sha J, Hendrix EK, Motin VL, Chopra AK.
    mBio; 2021 Dec 21; 12(6):e0322321. PubMed ID: 34872353
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
    Branger CG, Sun W, Torres-Escobar A, Perry R, Roland KL, Fetherston J, Curtiss R.
    Vaccine; 2010 Dec 16; 29(2):274-82. PubMed ID: 20979987
    [Abstract] [Full Text] [Related]

  • 12. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A, Rotem S, Zauberman A, Elia U, Aftalion M, Bar-Haim E, Mamroud E, Cohen O.
    Vaccine; 2017 Oct 20; 35(44):5995-6006. PubMed ID: 28606812
    [Abstract] [Full Text] [Related]

  • 13. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y, Flashner Y, Tidhar A, Zauberman A, Aftalion M, Lazar S, Gur D, Shafferman A, Mamroud E.
    Vaccine; 2011 Sep 16; 29(40):6866-73. PubMed ID: 21803090
    [Abstract] [Full Text] [Related]

  • 14. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
    Anderson GW, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM.
    Infect Immun; 1996 Nov 16; 64(11):4580-5. PubMed ID: 8890210
    [Abstract] [Full Text] [Related]

  • 15. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ.
    Vaccine; 2016 Nov 11; 34(47):5768-5776. PubMed ID: 27745954
    [Abstract] [Full Text] [Related]

  • 16. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
    Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R.
    Infect Immun; 2014 Oct 11; 82(10):4390-404. PubMed ID: 25114109
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
    Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK.
    Clin Vaccine Immunol; 2013 Feb 11; 20(2):227-38. PubMed ID: 23239803
    [Abstract] [Full Text] [Related]

  • 18. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.
    FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457
    [Abstract] [Full Text] [Related]

  • 19. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.
    Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.
    Eur J Immunol; 2010 Oct 15; 40(10):2791-6. PubMed ID: 20812236
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.
    Torres-Escobar A, Juárez-Rodríguez MD, Branger CG, Curtiss R.
    Vaccine; 2010 Aug 16; 28(36):5810-6. PubMed ID: 20600475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.